These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7638769)

  • 1. [The use of angiotensin-converting enzyme inhibitors in chronic diffuse kidney diseases].
    Kutyrina IM; Tareeva IE; Gerasimenko OI; Rogov VA; Miroshnichenko NG
    Ter Arkh; 1995; 67(5):20-3. PubMed ID: 7638769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
    Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H; Hayashi K; Saruta T
    J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute pharmacological block of the renin-angiotensin system and the recovery of intrarenal hemodynamics in patients with chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Zverev KV; Rogov VA
    Ter Arkh; 1993; 65(6):13-7. PubMed ID: 8378838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and cardiovascular effects of angiotensin-converting enzyme inhibitor plus angiotensin II receptor antagonist therapy in children with proteinuria.
    Lubrano R; Soscia F; Elli M; Ventriglia F; Raggi C; Travasso E; Scateni S; Di Maio V; Versacci P; Masciangelo R; Romero S
    Pediatrics; 2006 Sep; 118(3):e833-8. PubMed ID: 16923922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of angiotensin-converting enzyme inhibitors in chronic kidney insufficiency].
    Kutyrina IM; Lifshits NL; Rogov VA; Kamyshova ES; Shvetsov MIu; Okonova EB; Androsova SO; Martynov SA; Miroshnichenko NG; Gerasimenko OI
    Ter Arkh; 2002; 74(6):34-9. PubMed ID: 12136480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-I converting enzyme inhibition: clinical effects in chronic renal disease.
    de Jong PE; Heeg JE; Apperloo AJ; de Zeeuw D
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):85-8. PubMed ID: 2024682
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.
    Chrysostomou A; Becker G
    N Engl J Med; 2001 Sep; 345(12):925-6. PubMed ID: 11565535
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modification of renal hemodynamics and proteinuria in patients with arterial hypertension and kidney diseases].
    Risler T; Erley CM
    Z Kardiol; 1993; 82 Suppl 4():39-44. PubMed ID: 7908476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
    Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
    Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
    Camacho Díaz JA; Giménez Llort A; García García L; Jiménez González R
    An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients.
    van der Kleij FG; Navis GJ; Gansevoort RT; Heeg JE; Scheffer H; de Zeeuw D; de Jong PE
    Nephrol Dial Transplant; 1997; 12 Suppl 2():42-6. PubMed ID: 9269699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
    Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term renoprotective effect of combination therapy with prostaglandin E1 and angiotensin-converting enzyme inhibitor in patients with chronic renal failure.
    Nakayama Y; Nonoguchi H; Kiyama S; Kohda Y; Inoue T; Tomita K
    Hypertens Res; 2005 Sep; 28(9):733-9. PubMed ID: 16419646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.